Autonomize

Austin, United States Founded: 2021 • Age: 5 yrs
AI software for drug discovery and trial management is offered.

About Autonomize

Autonomize is a Healthcare company based in Austin (United States) founded in 2021 by Ganesh Padmanabhan and Kris Nair. AI software for drug discovery and trial management is offered. It operates in the Healthcare and Technology sectors. Autonomize has raised $32.02 million across 2 funding rounds from investors including Valtruis, Next Practices Group and Asset Management Ventures. Autonomize offers products and services including Prior Authorization Copilot, Care Gaps Review, Medical Record Review, Care Management, and Complex Document Processing. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its legal entity is Autonomize Inc. Its competitors include Medidata, Verily and TriNetX; 3 of its 3 listed competitors have raised funding.

Company details

Autonomize was founded in 2021 and is based in Austin, United States. Operations focus on the biotechnology sector, where AI-driven software is provided to researchers for drug targeting, toxicity assessment, and clinical trial management. Features include handling of biomedical and clinical data, along with workflow tools to support research processes. The platform aids in streamlining drug development activities.

  • Headquarters Austin, United States
  • Founders Ganesh Padmanabhan, Kris Nair
  • Sectors
    Healthcare
    Technology
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website autonomize.ai
  • Social LinkedIn X
  • Legal Name Autonomize Inc.
Key Metrics
  • Total Equity Funding
    $32.02M (USD)

    in 2 rounds

  • Latest Funding Round
    $28M (USD), Series A

    May 2025

  • Investors
    Valtruis

    & 7 more

Products & Services of Autonomize

Autonomize offers a comprehensive portfolio of products and services, including Prior Authorization Copilot, Care Gaps Review, Medical Record Review, Care Management, and Complex Document Processing.

Prior Authorization Copilot
AI Platform

Automates extraction and summarization of authorization requests for faster decisions.

Care Gaps Review
AI Tool

Identifies and addresses care gaps using patient data for better outcomes.

Medical Record Review
Data Analysis

Transforms unstructured medical data into structured insights for decision-making.

Care Management
Workflow Automation

Compiles case summaries from various sources to support informed patient care.

Complex Document Processing
AI Service

Structures and summarizes documents like contracts for actionable workflows.

Funding Insights of Autonomize

Autonomize has successfully raised a total of $32.02M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $28 million completed in May 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $32.02M
  • Total Rounds 2
  • Last Round Series A β€” $28M
  • First Round $4.02M

    (Apr 2023)

  • Investors Count 8

All 2 funding rounds of Autonomize with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2025$28MSeries A–Valtruis, Cigna Ventures
Apr 2023$4.02MSeed–Asset Management Ventures
Valuation history

8 investors in total: 8 institutional.

Investors in Autonomize

Autonomize has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Valtruis, Next Practices Group and Asset Management Ventures.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Early-stage US companies are invested in by Asset Management Ventures.
assetman.comPalo Alto, United States
Early-stage venture capital investments are made by ATX Venture Partners.
2014atxventurepartners.comAustin, United States
Loop Ventures is involved in venture capital activities.
loop.vc
VC firm focused on the healthcare industry
cignaventures.comBloomfield, United States
Seed-stage startups are funded by this venture capital firm.
tauventures.comPalo Alto, United States
Acceleration is provided to seed-stage, early-stage, and later-stage companies.
capitalfactory.comAustin, United States
Provider of business strategy, technology, healthcare, financial, legal, HR, and other consulting services
2020nextpracticesgroup.comAustin, United States
Health system management and data analytics services are provided.
2021valtruis.comNew York, United States
Premium access

Investor details for Autonomize

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Autonomize

21 people are tracked at Autonomize (7 in leadership, 14 in team).

NameRoleGroup
Ganesh Padmanabhan
Co-FounderLeadership
Kris Nair
Co-FounderLeadership
Doney Joseph
Sr Director - Operations | Sales | StrategyLeadership
Kaavya R
Director Of Engineering And QaLeadership
Scott Brennan
Head Of GrowthLeadership
Laksh Krishnamurthy
Chief Technology OfficerLeadership
🤘Ryan Kumar Ray
Head Of Delivery & Customer SuccessLeadership
Harshita Garg
Senior Software EngineerTeam
Surya Sandeep Boda
Software Engineering ManagerTeam
Adharsh C
Junior Data ScientistTeam
Jerry George
Cloud Solution ArchitectTeam
Akshay Gopal
Junior Data ScientistTeam
Simon K
Devops EngineerTeam
Ramsudharsan Manoharan
Senior Software EngineerTeam
Sandipan Basak
Senior Software DeveloperTeam
Nahyan Nabeel
junior software development engineerTeam
Nishi Viswanathan
Advisor, Healthcare AI StartupTeam
Joe Xavier
Senior Software EngineerTeam
Navaneeth K Parameswaran
Senior Software EngineerTeam
Janakiraman Rajendran
Senior Engineering ManagerTeam

1 more people are available in the full profile.

Premium access

Complete people profiles for Autonomize

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Autonomize

3 dated milestones of Autonomize across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Autonomize is founded.
  2. Funding First funding round of $4.0M.
  3. Funding Latest funding round, Series A, of $28.0M.

Competitors of Autonomize

Autonomize has 3 listed competitors in our database, 3 of them funded. They include Medidata, Verily and TriNetX.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
medidata.com1999New York, United States$41.5M1,677
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
verily.com2015Dallas, United States$2.5B
AI-based solutions for health management are provided.
trinetx.com2013Cambridge, United States$53M95
Clinical trial management software is provided for researchers and professionals.
Premium access

Detailed competitors of Autonomize

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Autonomize

The website of Autonomize (autonomize.ai) receives about 6.7K visits a month.

  • Monthly visits
    6.7K

    ▼ 39.4% vs previous month

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Autonomize (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Autonomize

Premium access

Complete news archive for Autonomize

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Autonomize

Autonomize was founded in 2021 and raised its 1st funding round 2 years after it was founded.

Autonomize is headquartered in Austin, United States. It is registered at Austin, Texas, United States.

Autonomize is a funded company, having raised a total of $32.02M across 2 funding rounds to date. The company's 1st funding round was a Seed of $4.02M, raised on Apr 2023.

Autonomize was founded in 2021 and is based in Austin, United States. Operations focus on the biotechnology sector, where AI-driven software is provided to researchers for drug targeting, toxicity assessment, and clinical trial management. Features include handling of biomedical and clinical data, along with workflow tools to support research processes. The platform aids in streamlining drug development activities.

Autonomize's top competitors include Medidata, Verily and TriNetX.

Autonomize offers Prior Authorization Copilot, Care Gaps Review, Medical Record Review, Care Management, and Complex Document Processing.

Autonomize has 8 investors. Key investors include Valtruis, Next Practices Group, Asset Management Ventures, ATX Venture Partners, and Loop Ventures.

Autonomize operates through Autonomize Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available